Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant

References

• Sandbulte MR, Spickler AR, Zaabel PK, Roth JA. Optimal use of vaccines for control of influenza a virus in Swine. Vaccines (Basel) 2015; 3:22-73; PMID:26344946; https://doi.org/10.3390/vaccines3010022
   PubMed Web of Science ®Google Scholar
• Stachyra A, Gora-Sochacka A, Sirko A. DNA vaccines against influenza. Acta Biochim Pol 2014; 61:515-22; PMID:25210719
   PubMed Web of Science ®Google Scholar
• Wong SS, Webby RJ. Traditional and new influenza vaccines. Clin Microbiol Rev 2013; 26:476-92; PMID:23824369; https://doi.org/10.1128/CMR.00097-12
   PubMed Web of Science ®Google Scholar
• Lu S, Wang S, Grimes-Serrano JM. Current progress of DNA vaccine studies in humans. Expert Rev Vaccines 2008; 7:175-91; PMID:18324888; https://doi.org/10.1586/14760584.7.2.175
   PubMed Web of Science ®Google Scholar
• Xiang K, Ying G, Yan Z, Shanshan Y, Lei Z, Hongjun L, Maosheng S. Progress on adenovirus-vectored universal influenza vaccines. Hum Vaccin Immunother 2015; 11:1209-22; https://doi.org/10.1080/21645515.2015.1016674
   PubMed Web of Science ®Google Scholar
• Lilja AE, Mason PW. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB. Vaccine 2012; 30:6980-90; PMID:23041121; https://doi.org/10.1016/j.vaccine.2012.09.056
   PubMed Web of Science ®Google Scholar
• de Vries RD, Rimmelzwaan GF. Viral vector-based influenza vaccines. Hum Vaccin Immunother 2016; 12(11):2881-901:0
   PubMed Web of Science ®Google Scholar
• Gray G, Buchbinder S, Duerr A. Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine. Curr Opin HIV AIDS 2010; 5:357-61; PMID:20978374; https://doi.org/10.1097/COH.0b013e32833d2d2b
   PubMed Web of Science ®Google Scholar
• Li L, Petrovsky N. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccines 2016; 15:313-29; PMID:26707950; https://doi.org/10.1586/14760584.2016.1096782
   PubMed Web of Science ®Google Scholar
• Corbet S, Vinner L, Hougaard DM, Bryder K, Nielsen HV, Nielsen C, Fomsgaard A. Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons. AIDS Res Hum Retroviruses 2000; 16:1997-2008; PMID:11153083; https://doi.org/10.1089/088922200750054738
   PubMed Web of Science ®Google Scholar
• Williams JA. Vector design for improved DNA vaccine efficacy, safety and production. Vaccines (Basel) 2013; 1:225-49; PMID:26344110; https://doi.org/10.3390/vaccines1030225
   PubMedGoogle Scholar
• Wang S, Zhang C, Zhang L, Li J, Huang Z, Lu S. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 2008; 26:2100-10; PMID:18378365; https://doi.org/10.1016/j.vaccine.2008.02.033
   PubMed Web of Science ®Google Scholar
• Bragstad K, Vinner L, Hansen MS, Nielsen J, Fomsgaard A. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection. Vaccine 2013; 31:2281-8; PMID:23499598; https://doi.org/10.1016/j.vaccine.2013.02.061
   PubMed Web of Science ®Google Scholar
• Hirao LA, Wu L, Khan AS, Satishchandran A, Draghia-Akli R, Weiner DB. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Vaccine 2008; 26:440-8; PMID:18082294; https://doi.org/10.1016/j.vaccine.2007.10.041
   PubMed Web of Science ®Google Scholar
• Borggren M, Nielsen J, Karlsson I, Dalgaard TS, Trebbien R, Williams JA, Fomsgaard A. A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs. Vaccine 2016; 34:3634-40; PMID:27211039; https://doi.org/10.1016/j.vaccine.2016.05.030
   PubMed Web of Science ®Google Scholar
• Fernando GJ, Zhang J, Ng HI, Haigh OL, Yukiko SR, Kendall MA. Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses. J Control Release 2016; 237:35-41; PMID:27381247; https://doi.org/10.1016/j.jconrel.2016.06.045
   PubMed Web of Science ®Google Scholar
• Nilsson C, Hejdeman B, Godoy-Ramirez K, Tecleab T, Scarlatti G, Brave A, Earl PL, Stout RR, Robb ML, Shattock RJ, et al. HIV-DNA given with or without intradermal electroporation is safe and highly immunogenic in healthy Swedish HIV-1 DNA/MVA vaccinees: A phase I randomized trial. PLoS One 2015; 10:e0131748; PMID:26121679; https://doi.org/10.1371/journal.pone.0131748
   PubMed Web of Science ®Google Scholar
• Ulmer JB, DeWitt CM, Chastain M, Friedman A, Donnelly JJ, McClements WL, Caulfield MJ, Bohannon KE, Volkin DB, Evans RK. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine 1999; 18:18-28; PMID:10501231; https://doi.org/10.1016/S0264-410X(99)00151-6
   PubMed Web of Science ®Google Scholar
• Liu J, Wu J, Wang B, Zeng S, Qi F, Lu C, Kimura Y, Liu B. Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection. J Med Virol 2014; 86:886-94; PMID:24122866; https://doi.org/10.1002/jmv.23768
   PubMed Web of Science ®Google Scholar
• Boyer JD, Cohen AD, Ugen KE, Edgeworth RL, Bennett M, Shah A, Schumann K, Nath B, Javadian A, Bagarazzi ML, et al. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids. AIDS 2000; 14:1515-22; PMID:10983638; https://doi.org/10.1097/00002030-200007280-00007
   PubMed Web of Science ®Google Scholar
• Barouch DH, Santra S, Tenner-Racz K, Racz P, Kuroda MJ, Schmitz JE, Jackson SS, Lifton MA, Freed DC, Perry HC, et al. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J Immunol 2002; 168:562-8; PMID:11777947; https://doi.org/10.4049/jimmunol.168.2.562
   PubMed Web of Science ®Google Scholar
• Flingai S, Czerwonko M, Goodman J, Kudchodkar SB, Muthumani K, Weiner DB. Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants. Front Immunol 2013; 4:354; PMID:24204366; https://doi.org/10.3389/fimmu.2013.00354
   PubMed Web of Science ®Google Scholar
• Zuber AK, Brave A, Engstrom G, Zuber B, Ljungberg K, Fredriksson M, Benthin R, Isaguliants MG, Sandström E, Hinkula J, et al. Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA. Vaccine 2004; 22:1791-8; PMID:15068863; https://doi.org/10.1016/j.vaccine.2003.10.051
   PubMed Web of Science ®Google Scholar
• Otero M, Calarota SA, Felber B, Laddy D, Pavlakis G, Boyer JD, Weiner DB. Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model. Vaccine 2004; 22:1782-90; PMID:15068862; https://doi.org/10.1016/j.vaccine.2004.01.037
   PubMed Web of Science ®Google Scholar
• Yu YZ, Ma Y, Xu WH, Wang S, Sun ZW. Combinations of various CpG motifs cloned into plasmid backbone modulate and enhance protective immunity of viral replicon DNA anthrax vaccines. Med Microbiol Immunol 2015; 204:481-91; PMID:25265876; https://doi.org/10.1007/s00430-014-0359-9
   PubMed Web of Science ®Google Scholar
• Billiau A, Matthys P. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 2001; 70:849-60; PMID:11739546
   PubMed Web of Science ®Google Scholar
• O'Hagan DT, Ott GS, De Gregorio E, Seubert A. The mechanism of action of MF59 - an innately attractive adjuvant formulation. Vaccine 2012; 30:4341-8; PMID:22682289; https://doi.org/10.1016/j.vaccine.2011.09.061
   PubMed Web of Science ®Google Scholar
• Ferrari L, Borghetti P, Gozio S, De Angelis E, Ballotta L, Smeets J, Blanchaert A, Martelli P. Evaluation of the immune response induced by intradermal vaccination by using a needle-less system in comparison with the intramuscular route in conventional pigs. Res Vet Sci 2011; 90:64-71; PMID:20546827; https://doi.org/10.1016/j.rvsc.2010.04.026
   PubMed Web of Science ®Google Scholar
• Visser N, Egger W, Lutticken D. Intradermal application of Aujeszky's disease virus strain Begonia with tocopherol-based adjuvant and a novel design injection device. Acta Vet Hung 1994; 42:413-8; PMID:7810440
   PubMed Web of Science ®Google Scholar
• Martelli P, Ferrari L, Morganti M, De Angelis E, Bonilauri P, Guazzetti S, Caleffi A, Borghetti P. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Vet Microbiol 2011; 149:339-51; PMID:21216540; https://doi.org/10.1016/j.vetmic.2010.12.008
   PubMed Web of Science ®Google Scholar
• Tengerdy RP, Henzerling RH, Brown GL, Mathias MM. Enhancement of the humoral immune response by vitamin E. Int Arch Allergy Appl Immunol 1973; 44:221-32; PMID:4574464; https://doi.org/10.1159/000230931
   PubMedGoogle Scholar
• Morel S, Didierlaurent A, Bourguignon P, Delhaye S, Baras B, Jacob V, Planty C, Elouahabi A, Harvengt P, Carlsen H, et al. Adjuvant System AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity. Vaccine 2011; 29:2461-73; PMID:21256188; https://doi.org/10.1016/j.vaccine.2011.01.011
   PubMed Web of Science ®Google Scholar
• Radhakrishnan AK, Mahalingam D, Selvaduray KR, Nesaretnam K. Supplementation with natural forms of vitamin E augments antigen-specific TH1-type immune response to tetanus toxoid. BioMed Res Int 2013; 2013:782067; PMID:23936847
   PubMed Web of Science ®Google Scholar
• Kang TH, Knoff J, Yeh WH, Yang B, Wang C, Kim YS, Kim TW, Wu TC, Hung CF. Treatment of tumors with vitamin E suppresses myeloid derived suppressor cells and enhances CD8+ T cell-mediated antitumor effects. PLoS One 2014; 9:e103562; PMID:25072795; https://doi.org/10.1371/journal.pone.0103562
   PubMed Web of Science ®Google Scholar
• Patel A, Dong JC, Trost B, Richardson JS, Tohme S, Babiuk S, Kusalik A, Kung SK, Kobinger GP. Pentamers not found in the universal proteome can enhance antigen specific immune responses and adjuvant vaccines. PLoS One 2012; 7:e43802; PMID:22937099; https://doi.org/10.1371/journal.pone.0043802
   PubMed Web of Science ®Google Scholar
• Borggren M, Nielsen J, Bragstad K, Karlsson I, Krog JS, Williams JA, Fomsgaard A. Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans. Hum Vaccin Immunother 2015; 11:1983-90; https://doi.org/10.1080/21645515.2015.1011987
   PubMed Web of Science ®Google Scholar
• Jegaskanda S, Job ER, Kramski M, Laurie K, Isitman G, de Rose R, Winnall WR, Stratov I, Brooks AG, Reading PC, et al. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J Immunol 2013; 190:1837-48; PMID:23319732; https://doi.org/10.4049/jimmunol.1201574
   PubMed Web of Science ®Google Scholar
• Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259:1745-9; PMID:8456302; https://doi.org/10.1126/science.8456302
   PubMed Web of Science ®Google Scholar
• Fu TM, Friedman A, Ulmer JB, Liu MA, Donnelly JJ. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J Virol 1997; 71:2715-21; PMID:9060624
   PubMed Web of Science ®Google Scholar